Chamomile
Standardised chamomile extract has real, replicated RCT support for reducing generalised anxiety symptoms over 8 weeks — one of the better-evidenced calming herbs. Its reputation as a sleep aid, by contrast, rests on far weaker data than its reputation suggests.
What the science says
- Reduces generalised anxiety symptoms Moderate evidence
In a randomised, double-blind, placebo-controlled trial of 57 patients with mild-to-moderate GAD, 8 weeks of Matricaria recutita extract (titrated up to 1,100 mg/day) produced a significantly greater fall in Hamilton Anxiety Rating Scale scores than placebo. A later open-label phase in a larger cohort replicated the symptom improvement, though both trials come from the same research group.
- Prevents relapse of anxiety after response Limited evidence
In a 26-week randomised continuation trial, patients who had responded to open-label chamomile were assigned to continue chamomile or switch to placebo. Relapse was numerically less frequent on chamomile, but the difference did not reach statistical significance — so long-term maintenance benefit is unproven.
- Improves sleep Limited evidence
Despite chamomile tea's cultural status as a bedtime drink, sleep trials are small, short and often in specific populations such as postnatal women or nursing-home residents, with mostly self-reported outcomes. Improvements in subjective sleep quality in the anxiety trials may simply follow from reduced anxiety rather than a direct hypnotic action.
Dosage & safety
Scientific references
Where to buy
Solaray, Vital Extracts, Chamomile, 325 mg, 30 VegCaps
View on iHerbReferral link — this site may earn a commission on purchases.
Related in Stress & mood
- Ashwagandha Moderate evidence
- L-Methylfolate Limited evidence
- 5-HTP Limited evidence
- L-Ornithine Limited evidence
- SAM-e Moderate evidence
- Rhodiola Rosea Limited evidence